A multicenter, non-randomized, open-label observational study to assess effectiveness of indacaterol as measured by patient reported outcomes in COPD patients in real life settings - INFLOW

Trial Profile

A multicenter, non-randomized, open-label observational study to assess effectiveness of indacaterol as measured by patient reported outcomes in COPD patients in real life settings - INFLOW

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 24 Aug 2016

At a glance

  • Drugs Indacaterol (Primary) ; Indacaterol (Primary) ; Formoterol; Salmeterol; Tiotropium bromide
  • Indications Chronic obstructive pulmonary disease
  • Focus Therapeutic Use
  • Acronyms INFLOW
  • Sponsors Novartis
  • Most Recent Events

    • 12 Dec 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top